Skip to main content Skip to section navigation Skip to footer
Morphogenesis Inc. morphogenesis logo white morphogenesis logo color
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Pipeline & Technologies
    • Overview
    • Our Technologies
    • IFx-Hu2.0
    • IFx-Hu3.0
    • Tumor Microenvironment Modulators
    • Scientific Publications
  • Patient Resources
    • Overview
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Contact

Press Releases

Morphogenesis, Inc. and CohBar, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

The companies hosted a joint webcast on May 23, 2023, to discuss the transaction.

CohBar Website

Access Webcast Replay
News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
May 30, 2023

Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

May 23, 2023

CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

rss_feed RSS
©2023 Morphogenesis Inc. All Rights Reserved.
Privacy Policy Sitemap Terms of Use